Back

Dose-response relationship of extended-release methylphenidate for ADHD in adults: post-hoc analysis based on a systematic review

Boesen, K.; Jorgensen, K. J.; Gotzsche, P. C.

2021-12-09 psychiatry and clinical psychology
10.1101/2021.12.08.21267468 medRxiv
Show abstract

ObjectiveTo assess potential dose-response relationships of extended-release methylphenidate for ADHD in adults on efficacy outcomes. Study design and settingPost-hoc analysis based on a systematic review of extended-release methylphenidate (https://doi.org/10.1002/14651858.CD012857). Using data from clinical trials comparing multiple fixed-dose methylphenidate groups with placebo, we conducted subgroup meta-analyses for available efficacy outcomes. Results and conclusionFive trials used a fixed-dose design with multiple methylphenidate groups receiving different doses. All trials were pivotal industry sponsored studies conducted to obtain marketing authorisation. We analysed four efficacy outcomes: Selfrated ADHD symptoms (5 trials, 1807 participants), investigator-rated ADHD symptoms (5 trials, 1904 participants), quality of life (4 trials, 1158 participants), and peer-rated ADHD symptoms (2 trials, 879 participants). There were no dose-response relationships for any outcome.

Matching journals

The top 14 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.